Abstract: Disclosed herein is a method for alleviating dry eye syndrome using a composition containing a polylysine nanoparticle. The polylysine nanoparticle is produced by subjecting lysine hydrochloride to a pyrolysis treatment at a temperature ranging from 240° C. to 280° C.

Abstract: Provided is a nanogel exhibiting anticoagulation and antioxidation activities, including a graphene-like nanosheet and a polysaccharide, which are complexed to form a cross-linked supramolecular structure. Also provided is a method of preparing the nanogel, including carbonizing the polysaccharide by dry heating. By the heating process, at least a portion of the polysaccharide is conversed into the graphene-like nanosheet, thereby forming a graphene-like nanosheet-embedded phenolic-polysaccharide nanogel that has exceptional polyphenolic structure and high binding affinity toward thrombin. Further provided is a method of preventing or treating a disease or a condition susceptible to amelioration by anticoagulants or antioxidants by using the nanogel.

Abstract: Provided is a nanogel exhibiting anticoagulation and antioxidation activities, including a graphene-like nanosheet and a polysaccharide, which are complexed to form a cross-linked supramolecular structure. Also provided is a method of preparing the nanogel, including carbonizing the polysaccharide by dry heating. By the heating process, at least a portion of the polysaccharide is conversed into the graphene-like nanosheet, thereby forming a graphene-like nanosheet-embedded phenolic-polysaccharide nanogel that has exceptional polyphenolic structure and high binding affinity toward thrombin. Further provided is a method of preventing or treating a disease or a condition susceptible to amelioration by anticoagulants or antioxidants by using the nanogel.

Abstract: In some implementations, a computing device may perform a method for providing a unified pipeline for media metadata to converge disparate schemas and data structures into a global unified graph. The method includes receiving media metadata from disparate media sources that may each have a different metadata schema that defines the structure and attributes of the metadata provided by each media source. The computing device may compare media metadata received from the different media sources to determine that metadata received from the different media sources correspond to similar, or the same, media entities (e.g., songs, movies, books, etc.). The metadata for the similar media entities may then be combined into a global unified graph that may include metadata attributes and/or values of the metadata received from the various media sources.

Abstract: Generation of chimeric non-human animals hosting bat donor cells involves chimeric mice having bat cells that may be stably tolerated to provide a new platform technology in the general field of biology, and having application in the field of immunology related to virus-host interaction, cancer biology, autoimmunity, and the development of new drugs.

Abstract: In some implementations, a computing device may perform a method for providing a unified pipeline for media metadata to converge disparate schemas and data structures into a global unified graph. The method includes receiving media metadata from disparate media sources that may each have a different metadata schema that defines the structure and attributes of the metadata provided by each media source. The computing device may compare media metadata received from the different media sources to determine that metadata received from the different media sources correspond to similar, or the same, media entities (e.g., songs, movies, books, etc.). The metadata for the similar media entities may then be combined into a global unified graph that may include metadata attributes and/or values of the metadata received from the various media sources.

Abstract: The present invention provides a method for eicosapentaenoic acid (EPA) and/or arachidonic acid (ARA) production by using Halophytophthora and Halophytophthora isolates that are suitable for EPA and/or ARA production. The disclosure of the present invention provides another choice for the industry to produce EPA and ARA that are good for human's health and promotes the industrial value of Halophytophthora.

Abstract: A system for executing actions includes a database established with a plurality of reference strings and correspondence of each of the reference strings to at least one predefined action, and a mobile device communicatively coupled with the database. The mobile device includes an input unit for inputting a to-be-compared string, and a processor electrically coupled with the input unit. The processor is configured to search the database to find a string set of one or more of the reference strings that matches the to-be-compared string, and execute the at least one predefined action corresponding to the one or more of the reference strings of the string set found by the processor.

Abstract: The present invention provides a method for eicosapentaenoic acid (EPA) and/or arachidonic acid (ARA) production by using Halophytophthora and Halophytophthora isolates that are suitable for EPA and/or ARA production. The disclosure of the present invention provides another choice for the industry to produce EPA and ARA that are good for human's health and promotes the industrial value of Halophytophthora.

Abstract: A method of cross-linking a peptide to form a homopolymer of the peptide, to immobilize the peptide on a solid phase and to enhance antigenicity of the peptide is disclosed. The method comprises the steps of preparing a fusion peptide by incorporating a cross-linking segment including a tetrapeptide sequence Q-X-K-(S/T) (SEQ ID NO: 15) into the peptide and cross-linking the peptide by a glutaminase.

Abstract: A method of cross-linking a peptide to form a homopolymer of the peptide, to immobilize the peptide on a solid phase and to enhance antigenicity of the peptide is disclosed. The method comprises the steps of preparing a fusion peptide by incorporating a cross-linking segment including a tetrapeptide sequence Q-X-K-(S/T) (SEQ ID NO: 15) into the peptide and cross-linking the peptide by a glutaminase.

Abstract: A method of cross-linking a peptide to form a homopolymer of the peptide, to immobilize the peptide on a solid phase and to enhance antigenicity of the peptide is disclosed. The method comprises the steps of preparing a fusion peptide by incorporating a cross-linking segment including a tetrapeptide sequence QXK(S/T) into the peptide and cross-linking the peptide by a glutaminase.